CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

BACKGROUND: Dedifferentiated liposarcoma (DDLPS) is one of the most common soft tissue sarcoma subtypes and is devastating in the advanced/metastatic stage. Despite the observation of clinical responses to PD-1 inhibitors, little is known about the immune microenvironment in relation to patient prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Brett A, LaFranzo, Natalie A, LaFleur, Bonnie J, Gittelman, Rachel M, Vignali, Marissa, Zhang, Shihong, Flanagan, Kevin C, Rytlewski, Julie, Riolobos, Laura, Schulte, Brian C, Kim, Teresa S, Chen, Eleanor, Smythe, Kimberly S, Wagner, Michael J, Mantilla, Jose G, Campbell, Jean S, Pierce, Robert H, Jones, Robin L, Cranmer, Lee D, Pollack, Seth M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413967/
https://www.ncbi.nlm.nih.gov/pubmed/34465597
http://dx.doi.org/10.1136/jitc-2021-002812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413967/
https://www.ncbi.nlm.nih.gov/pubmed/34465597
http://dx.doi.org/10.1136/jitc-2021-002812

Ejemplares similares